Sex Hormones and the Risk of Alveolar Osteitis After Dental Extraction

By Ayesha Khan, MBA

Alveolar osteitis (AO), commonly known as dry socket, remains one of the most common postoperative complications following tooth extraction, particularly after impacted mandibular third molar surgery. Despite advances in surgical techniques, improved postoperative protocols, and a better understanding of wound healing, dry socket continues to affect approximately 1–5% of routine extractions and up to 30% of surgical third molar removals. This persistent incidence highlights the important role of patient-specific biological factors in determining postoperative outcomes.

Among these factors, sex hormones, particularly estrogen, have attracted increasing attention for their influence on clot stability and socket healing. A growing body of clinical evidence indicates that both natural hormonal fluctuations during the menstrual cycle and exogenous estrogen from combined oral contraceptives (COCs) can increase the risk of alveolar osteitis. For dentists and oral surgeons, understanding these mechanisms can improve risk assessment, treatment planning, and patient education.

Understanding Alveolar Osteitis

Alveolar osteitis develops when the blood clot within the extraction socket is lost prematurely or fails to organize properly. Without this protective clot, the underlying alveolar bone and nerve endings become exposed, resulting in:

• Severe postoperative pain beginning 24–72 hours after extraction.
• Empty or partially empty extraction socket.
• Exposed bone.
• Halitosis.
• Delayed wound healing.

Unlike postoperative infection, dry socket is primarily considered a disorder of impaired clot stability, making factors that influence coagulation and fibrinolysis particularly important. Although self-limiting, AO significantly affects patient quality of life and frequently results in emergency postoperative visits.

The Biological Role of Sex Hormones, Particularly Estrogen

Successful socket healing depends on formation and maintenance of a stable fibrin clot. This clot serves as a biologic scaffold for inflammatory cells, fibroblasts, endothelial cells, and osteogenic progenitor cells that initiate tissue repair.

Elevated estrogen levels influence several components of coagulation and fibrinolysis. While estrogen promotes certain coagulation factors, it also enhances fibrinolytic activity by increasing plasminogen activation and reducing plasminogen activator inhibitor-1 (PAI-1). Excessive fibrinolysis accelerates degradation of the extraction clot.

Clinically, this means:

• Earlier clot dissolution.
• Greater likelihood of socket exposure.
• Delayed epithelial migration.
• Increased postoperative pain.

Beyond fibrinolysis, elevated estrogen may also:

• Alter inflammatory mediator expression during early wound healing.
• Influence angiogenesis and vascular permeability.
• Affect local immune responses and bacterial interactions within the extraction socket.

Progesterone also influences vascular permeability and inflammatory responses, although current evidence suggests estrogen has the more significant impact on AO development.

Oral Contraceptives

Among all hormone-related variables, combined oral contraceptives possess the strongest clinical evidence.

A 2022 systematic review and meta-analysis evaluating 15 studies involving more than 4,200 women found that oral contraceptive users were approximately twice as likely to develop alveolar osteitis following third molar extraction compared with women not using oral contraceptives.

Key findings included:

• Female patients not using oral contraceptives demonstrated a risk similar to males.
• Antibiotic or postoperative analgesic use did not eliminate the increased risk associated with oral contraceptives.

More recent systematic reviews continue to support this association. A 2024 PRISMA-based review concluded that hormonal contraceptives are consistently associated with an increased likelihood of alveolar osteitis while also influencing several other oral conditions, including gingival inflammation and periodontal changes.

Menstrual Cycle Timing

Natural hormonal fluctuations during the menstrual cycle may also affect postoperative healing. Several observational studies suggest that extractions performed during the mid-cycle (ovulatory) phase, when circulating estrogen concentrations peak, are associated with higher rates of alveolar osteitis than procedures performed during the menstrual or luteal phases.

While the available evidence remains heterogeneous and does not yet justify universal scheduling recommendations, awareness of menstrual timing may contribute to individualized risk assessment, particularly for patients with multiple concurrent risk factors such as:

• Smoking and vaping.
• Traumatic extraction.
• Surgical difficulty.
• Impacted mandibular third molars.
• Poor oral hygiene.
• Previous history of dry socket.
• Inadequate irrigation.
• Excessive surgical trauma.
• Pre-existing local infection.

Patients using oral contraceptives who also smoke represent an especially high-risk group because both factors independently impair clot stability and wound healing.

Clinical Implications for Dental Professionals

Evidence-based risk reduction begins with thorough medical history taking.

Preoperative assessment should routinely include questions regarding:

• Combined oral contraceptive use.
• Hormone replacement therapy.
• Pregnancy status.
• Smoking habits.
• Previous dry socket experience.

For elective surgical extractions, clinicians may consider:

• Scheduling procedures during lower-estrogen phases when practical.
• Minimizing surgical trauma.
• Copious irrigation during extraction.
• Careful socket debridement.
• Appropriate use of local preventive measures in high-risk patients.
• Providing enhanced postoperative instructions emphasizing clot preservation.

Importantly, patients should never discontinue prescribed hormonal contraception without consulting their physician. Instead, clinicians should focus on risk awareness and evidence-based preventive strategies.

Conclusion

The current body of evidence strongly supports a relationship between sex hormones—particularly estrogen—and alveolar osteitis risk after dental extraction. Elevated estrogen levels appear to increase fibrinolytic activity, destabilize the extraction clot, and predispose susceptible patients to dry socket.

For dental professionals, this evidence reinforces the importance of comprehensive medical histories, individualized risk assessment, atraumatic surgical techniques, and patient-specific postoperative care. As research continues to clarify the interplay between endocrine physiology and oral wound healing, integrating hormonal considerations into routine clinical practice may further reduce postoperative complications and improve patient outcomes.

References:

1. Moudahik, Z., El Wadidi, N., Farih, Z., Khazana, M., & Naji, Y. (2026). Influence of sex hormones on the risks of alveolar osteitis after dental extraction. Advances in Oral and Maxillofacial Surgery, 100685.
2. Tandon, P., Sahoo, S. K., Mohanty, L., Jain, N., Hittalamani, V., Kamble, S. S., & Singh, R. (2024). Dry socket prevalence and risk factors in third molar extractions: a prospective observational study. Cureus, 16(3).
3. Tang, M., Gurpegui Abud, D., & Shariff, J. A. (2022). Oral Contraceptive Use and Alveolar Osteitis Following Third Molar Extraction: A Systematic Review and Meta‐Analysis. International Journal of Dentistry, 2022(1), 7357845.
4. Rojo, M. G., Lloret, M. R. P., & Gironés, J. G. (2024). Oral manifestations in women using hormonal contraceptive methods: a systematic review. Clinical Oral Investigations, 28(3), 184.

Author: Ayesha Khan, MBA, is a former research fellow and award-winning author. With a wide range of articles published in renowned newspapers and scientific journals, she covers topics such as nutrition, wellness, supplements, medical research, and alternative medicine. Currently serving as the Vice President of Social Communications and Strategy at Renaissance, Ayesha brings her expertise and strategic mindset to drive impactful initiatives. Follow her blog for insightful content on healthcare advancements and empower yourself with knowledge.